| 摘要 |
The invention relates to tablets comprising deramciclane-fumarate of the Formula (I) whereby said tablets contain (related to the total weight) more than 50 % by weight of deramciclane-fumarate, 5-20 % by weight of a binder, 5-20 % by weight of microcrystalline cellulose having an average particle size below 30 mum, 1-10 % by weight of a disintegrant, 0.5-4 % by weight of a lubricant, 0.5- 4 % by weight of an anti-adhesive agent and 0-30 % by weight of a filler. Deramciclane-fumarate is a known anxiolytic active ingredient.
|
